The effect of single-dose naproxen on eicosanoid formation in human gastroduodenal mucosa

Alimentary Pharmacology and Therapeutics

Volumn 23, Issue 1, 2006, Pages 155-167

  Treiber, G ^a   Wex, T ^a   Link, A ^a   Vieth, M ^a   Laufer, S ^b   Malfertheiner, P ^a  

^a UNIVERSITY HOSPITAL MAGDEBURG   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONATE 5 LIPOXYGENASE; CYCLOOXYGENASE 2; ICOSANOID; LEUKOTRIENE; LEUKOTRIENE B4; NAPROXEN; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE; THROMBOXANE B2;

ADULT; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG EFFECT; DUODENUM MUCOSA; FEMALE; HELICOBACTER PYLORI; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; MALE; NORMAL HUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SERUM; SINGLE DRUG DOSE; STOMACH ANTRUM; STOMACH MUCOSA;

ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CYCLOOXYGENASE INHIBITORS; EICOSANOIDS; FEMALE; GASTRIC MUCOSA; HUMANS; LEUKOTRIENE B4; MALE; NAPROXEN; PROSTAGLANDINS E; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; THROMBOXANE B2;

EID: 33644920731     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2006.02725.x     Document Type: Article

References (54)

1. Wolfe N Lichtenstein D Singh G Gastrointestinal toxicity of non-steroidal anti-inflammatory drugs N Engl J Med 1999 340 1888 99
2. Hawkey C Langman M Non-steroidal anti-inflammatory drugs: overall risks and management. Complementary roles for Cox-2 inhibitors and proton pump inhibitors Gut 2003 52 600 8
3. Chan F Leung W Peptic ulcer disease Lancet 2002 360 933 41
4. Rodriguez L Hernandez-Diaz S Risk of uncomplicated peptic ulcer among users of aspirin and nonaspirin nonsteroidal antiinflammatory drugs Am J Epidemiol 2004 159 23 31
5. Derry S Loke Y Risk of gastrointestinal haemorrhage with long-term use of aspirin: meta-analysis Br Med J 2000 321 1183 7
6. MacDonald T Wei L Effect of ibuprofen on cardioprotective effect of aspirin Lancet 2003 361 573 4
7. Curtis J Wang Y Portnay E Masoudi F Havranek E Krumholz H Aspirin, ibuprofen, and mortality after myocardial infarction: retrospective cohort study BMJ 2003 327 1322 3
8. Garcia Rodriguez L Varas-Lorenzo C Maguire A Gonzalez-Perez A Nonsteroidal anti-inflammatory drugs and the risk of myocardial infarction in the general population Circulation 2004 109 3000 6
9. Patel T Goldberg K Use of aspirin and ibuprofen compared with aspirin alone and the risk of myocardial infarction Arch Intern Med 2004 164 852 6
10. Kurth T Glynn R Walker A et al. Inhibition of clinical benefits of aspirin on first myocardial infarction by nonsteroidal anti-inflammatory drugs Circulation 2003 108 1191 5
11. FitzGerald G Coxibs and cardiovascular disease N Engl J Med 2004 351 1709 11
12. Griffin M Stein C Cardiovascular toxicity of valdecoxib N Engl J Med 2004 351 2767
13. Rainsford KD Mechanisms of gastrointestinal damage by NSAIDS Agents Actions Suppl 1993 44 59 64
14. Wallace J McKnight W Reuter BK Vergnolle N NSAID-induced gastric damage in rats: requirement for inhibition of both cyclooxygenase 1 and 2 Gastroenterology 2000 119 706 14
15. FitzGerald G Patrono C The coxibs, selective inhibitors of cyclooxygenase-2 N Engl J Med 2001 345 433 42
16. Higham J Kang J Majeed A Recent trends in admissions and mortality due to peptic ulcer in England: increasing frequency of haemorrhage among older subjects Gut 2002 50 460 4
17. Silverstein F Faich G Goldstein J et al. Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs für osteoarthritis and rheumatoid arthritis. The CLASS Study: a randomized controlled trial JAMA 2000 284 1247 55
18. Bombardier C Laine L Reicin A et al. Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis N Engl J Med 2000 343 1520 8
19. Laine L Maller E Yu C Quan H Simon T Ulcer formation with low-dose enteric-coated aspirin and the effect of cox-2 selective inhibition: a double-blind trial Gastroenterology 2004 127 395 402
20. Schnitzer T Burmester G Mysler E et al. Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), reduction in ulcer complications Lancet 2004 364 665 74
21. Hawkey C Tulassay Z Szczepanski L et al. Randomised controlled trial of Helicobacter pylori eradication in patients on non-steroidal anti-inflammatory drugs: HELP NSAIDs study. Helicobacter Eradication for Lesion Prevention Lancet 1998 352 1016 21
22. Haeggstroem J Wetterholm A Enzymes and receptors in the leukotriene cascade Cell Mol Life Sci 2002 59 742 53
23. Funk C Prostaglandins and leukotrienes: advances in eicosanoid biology Science 2001 294 1871 5
24. Rainsford K Inhibition by leukotriene inhibitors, and calcium and platelet-activating factor antagonists, of acute gastric and intestinal damage in arthritic rats and in cholinomimetic-treated mice J Pharm Pharmacol 1999 51 331 9
25. Kirchner T Aparicio B Argentieri D Lau C Ritchie D Effects of tepoxalin, a dual inhibitor of cyclooxygenase/5-lipoxygenase, on events associated with NSAID-induced gastrointestinal inflammation Prostaglandins Leukot Essent Fatty Acids 1997 56 417 23
26. Fiorucci S Santucci L Gresele P Luinetti O Morelli A Effect of NSAIDs on pepsinogen secretion and calcium mobilization in isolated chief cells Am J Physiol 1995 268 968 78
27. Pihan G Rogers C Szabo S Vascular injury in acute gastric mucosal damage. Mediatory role of leukotrienes Dig Dis Sci 1988 33 625 32
28. Fukuda T Arakawa T Kobayashi K Roles of endogenous leukotrienes in damage caused by ethanol in isolated rat gastric cells J Clin Gastroenterol 1988 10 Suppl. 1 S140 5
29. Celotti F Laufer S Anti-inflammatory drugs: new multitarget compounds to face an old problem. The dual inhibition concept Pharmacol Res 2001 43 429 36
30. Tries S Neupert W Laufer S The mechanism of action of the new antiinflammatory compound ML-3000: inhibition of 5-LOX and COX-1/2 Inflamm Res 2002 51 135 43
31. Martel-Pelletier J Lajeunesse D Reboul P Pelletier J-P Therapeutic role of dual inhibitors of 5-lox and cox, selective and non-selective non-steroidal anti-inflammatory drugs Ann Rheum Dis 2003 62 501 9
32. Ackermann Z Karmeli F Ligumsky M Rachmilewitz D Enhanced gastric and duodenal platelet-activating factor and leukotriene generation in duodenal ulcer patients Scand J Gastroenterol 1990 25 925 34
33. Hudson N Balsitis M Everitt S Hawkey C Enhanced gastric mucosal leukotriene B4 synthesis in patients taking non-steroidal anti-inflammatory drugs Gut 1993 34 742 7
34. Malfertheiner P Mantzaris GJ Farthing M et al. Recommendations of the ESGE Workshop on Ethics in Gastrointestinal Endoscopy-based Research. First European Symposium on Ethics in Gastroenterology and Digestive Endoscopy, Kos, Greece, June 2003 Endoscopy 2003 35 775 7
35. Wex T Treiber G Lendeckel U Malfertheiner P A two step method for the extraction of high-quality RNA from endoscopic biopsies Clin Chem Lab Med 2003 41 1033 7
36. Aulock S Hermann C Hartung T Determination of the eicosanoid response to inflammatory stimuli in whole blood and its pharmacological modulation ex vivo J Immunol Methods 2003 277 53 63
37. Tegeder I Pfeilschifter J Geisslinger G Cyclooxygenase-independent actions of cyclooxygenase inhibitors FASEB J 2001 15 2057 72
38. Jackson LM Wu KC Mahida YR Jenkins D Hawkey CJ Cyclooxygenase (COX) 1 and 2 in normal, inflamed, and ulcerated human gastric mucosa Gut 2000 47 762 70
39. Silverstein F Graham D Senior J et al. Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs. A randomized, double-blind, placebo-controlled trial Ann Intern Med 1995 123 241 9
40. Wallace J Zamuner S McKnight W et al. Aspirin, but not NO-releasing aspirin (NCX-4016), interacts with selective cox-2 inhibitors to aggravate gastric damage and inflammation Am J Physiol Gastrointest Liver Physiol 2004 286 G76 81
41. Fiorucci S Santucci L Wallace J et al. Interaction of a selective cyclooxygenase-2 inhibitor with aspirin and NO-releasing aspirin in the human gastric mucosa Gastroenterology 2002 123 1598 606
42. Lichtenberger L Romero J DeRuiter W et al. Phosphatidylcholine association increases the anti-inflammatory and analgesic activity of ibuprofen in acute and chronic rodent models of joint inflammation: relationship to alterations in bioavailability and cyclooxygenase-inhibitory potency J Pharmacol Exp Ther 2001 298 279 87
43. Anand B Romero J Sanduja S Lichtenberger L Phospholipid association reduces the gastric mucosal toxicity of aspirin in human subjects Am J Gastroenterol 1999 94 1818 22
44. Bias P Buchner A Klesser B Laufer S The gastrointestinal tolerability of the LOX/COX inhibitor, licofelone, is similar to placebo and superior to naproxen therapy in healthy volunteers: results from a randomized, controlled trial Am J Gastroenterol 2004 99 611 8
45. Fiorucci S Distrutti E Menezes de Lima O et al. Relative contribution of acetylated cyclo-oxygenase (COX)-2 and 5-lipoxygenase (LOX) in regulating gastric mucosal integrity and adaptation to aspirin FASEB 2003 17 1171 3
46. Cryer B Feldman M Effects of very low dose daily, long-term aspirin therapy on gastric, duodenal, and rectal prostaglandin levels and on mucosal injury in healthy humans Gastroenterology 1999 117 17 25
47. Feldman M Shewmake K Cryer B Time course inhibition of gastric and platelet COX activity by acetylsalicylic acid in humans Am J Physiol Gastrointest Liver Physiol 2000 279 G1113 20
48. Halter F Tarnawski AS Schmassmann A Peskar BM Cyclooxygenase 2-implications on maintenance of gastric mucosal integrity and ulcer healing: controversial issues and perspectives Gut 2001 49 443 53
49. Fiorucci S Antonelli E Cyclo-oxygenase isoenzymes. Structural basis for selective inhibition of cyclo-oxygenases by anti-inflammatory agents Dig Liver Dis 2001 33 Suppl. 2 S2 7
50. Zimmermann KC Sarbia M Schror K Weber AA Constitutive cyclooxygenase-2 expression in healthy human and rabbit gastric mucosa Mol Pharmacol 1998 54 536 40
51. Komori M Tsuji S Sun WH et al. Gastrin enhances gastric mucosal integrity through cyclooxygenase-2 upregulation in rats Am J Physiol Gastrointest Liver Physiol 2002 283 G1368 78
52. Tanaka A Hase S Miyazawa T Takeuchi K Up-regulation of cyclooxygenase-2 by inhibition of cyclooxygenase-1: a key to nonsteroidal anti-inflammatory drug-induced intestinal damage J Pharmacol Exp Ther 2002 300 754 61
53. Gallego-Sandin S Novalbos J Rosado A et al. Effect of ibuprofen on cyclooxygenase and nitric oxide synthase of gastric mucosa: correlation with endoscopic lesions and adverse reactions Dig Dis Sci 2004 49 1538 44
54. Darling R Romero J Dial E Akunda J Langenbach R Lichtenberger L The effects of aspirin on gastric mucosal integrity, surface hydrophobicity, and prostaglandin metabolism in cyclooxygenase knockout mice Gastroenterology 2004 127 94 104